Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-01 Sale |
2020-12-03 6:05 pm |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A President and COO |
15,000 | $22.97 | $344,513 | 17,659 (Direct) |
View |
| 2020-11-23 Sale |
2020-11-25 4:38 pm |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
29,972 | $23.16 | $694,121 | 0 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-12 5:55 pm |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
80,404 | $20.04 | $1,611,577 | 46,565 (Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 5:55 pm |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A President and COO |
100,000 | $20.31 | $2,031,410 | 17,659 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-01 Exercise |
2020-12-03 6:05 pm |
N/A 2025-06-01 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A President and COO |
15,000 | $0 | 17,659 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 6:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A President and COO |
15,000 | $7.2 | 17,659 (Direct) |
View |
| 2020-11-23 Exercise |
2020-11-25 4:38 pm |
N/A 2023-05-09 |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
29,972 | $0 | 0 (Direct) |
View |
| 2020-11-23 Exercise |
2020-11-25 4:38 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer |
29,972 | $3.08 | 0 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:55 pm |
N/A 2025-06-01 |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
80,404 | $0 | 46,565 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:55 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Morrison Briggs Chief Executive Officer |
80,404 | $7.2 | 46,565 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 5:55 pm |
N/A 2025-06-01 |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A President and COO |
100,000 | $0 | 17,659 (Direct) |
View |
| 2020-11-04 Exercise |
2020-11-06 5:55 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Metzger Michael A President and COO |
100,000 | $7.2 | 17,659 (Direct) |
View |
Ownership |
2020-07-13 08:28 am |
N/A 2030-05-12 |
Syndax Pharmaceuticals Inc | SNDX | Karydas Daphne Chief Financial Officer |
0 | $0 | 215,000 (Direct) |
View |
| 2020-07-06 Option Award |
2020-07-08 4:11 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer |
3,500 | $0 | 10,730 (Direct) |
View |